印度社区获得性呼吸道感染背景下的抗菌药物耐药性国家数据:抗生素敏感性、地方与国际抗生素处方指南、药物可及性与临床结局之间的联系
该指南性文章综述了印度抗菌药物耐药性(AMR)现状及应对举措,识别了社区获得性呼吸道感染关键病原体(肺炎链球菌和流感嗜血杆菌)药敏数据可及性、国家与国际抗生素处方指南使用及当地抗生素可及性等信息缺口。文章指出印度已启动多项AMR国家倡议并发布五年国家行动计划,但传染病负担和抗生素消费量高,建议采用更标准化且基于当地最新监测数据的综合方法制定地方指南,以促进更合理抗生素处方并改善依从性,从而可能限制AMR发展并改善患者结局。
要点
- 印度已将AMR列为国家优先事项并发布五年国家行动计划,但传染病负担和抗生素消费量仍高。
- 针对常见呼吸道感染,临床医生使用多种国际和国内指南,缺乏标准化本地指南。
- 采用基于当地社区获得性感染最新监测数据的更标准化综合方法制定地方指南,可提高指南本地相关性。
核心结论
- 印度已启动多项AMR国家倡议并发布五年国家行动计划,但传染病负担和抗生素消费量高。
- 采用基于当地最新社区获得性感染监测数据的更标准化综合方法制定地方指南,可促进更合理抗生素处方并改善依从性,从而可能限制AMR发展并改善患者结局。
研究设计与样本
- 该指南性文章识别了印度国家AMR倡议、抗生素使用与处方情况以及关键社区获得性呼吸道感染病原体(肺炎链球菌和流感嗜血杆菌)的药敏数据可及性。
- 文章还回顾了当地常用的针对特定社区获得性呼吸道感染(社区获得性肺炎、急性中耳炎和急性细菌性鼻窦炎)的国家和国际抗生素处方指南,以及当地抗生素可及性,并征求了当地临床医生和临床微生物学家的见解。
主要发现
- 自AMR被认定为国家优先事项以来已启动多项倡议,印度儿科学会和全球抗生素耐药伙伴关系等组织致力于提高认识。
- 印度卫生和家庭福利部发布了五年国家AMR行动计划。
- 印度传染病负担和抗生素消费量高。
- 已有国家监测研究及国际研究(如抗生素耐药性调查SOAR和抗菌药物检测领导与监测ATLAS)产生当地数据。
- 对于常见呼吸道感染,临床医生使用多种国际和国内指南。
关键数值与推荐
- 印度卫生和家庭福利部发布了五年国家AMR行动计划。
- 国家监测研究及国际研究如SOAR和ATLAS已产生当地数据。
- 针对社区获得性肺炎、急性中耳炎和急性细菌性鼻窦炎,临床医生使用多种国际和国内指南。
临床怎么用
- 采用基于当地社区获得性感染最新监测数据的更标准化综合方法制定地方指南,可使指南更具本地相关性。
- 这将鼓励更合理的抗生素处方并提高依从性,进而可能限制AMR发展并改善患者结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. OBJECTIVES: To review the current situation with respect to AMR in India and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize further rises in AMR and to improve patient outcomes. METHODS: National AMR initiatives, antibiotic use and prescribing in India, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens (Streptococcus pneumoniae and Haemophilus influenzae) were identified. National and international antibiotic prescribing guidelines for specific CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, plus local antibiotic availability. Insights from a local clinician and clinical microbiologist were sought to contextualize this information. CONCLUSIONS: Many initiatives have been launched since AMR was recognized as a national priority and organizations such as the Indian Academy of Paediatrics and the Global Antibiotic Resistance Partnership have worked to build awareness. The Indian Ministry of Health and Family Welfare published a 5 year national action plan on AMR. However, the burden of infectious disease and consumption of antibiotics in India is high. There have been national surveillance studies generating local data along with international studies such as Survey of Antibiotic Resistance (SOAR) and Antimicrobial Testing Leadership and Surveillance (ATLAS). For common RTIs, clinicians use a range of international and national guidelines. However, a more standardized inclusive approach to developing local guidelines, using up-to-date local surveillance data from community-acquired infections, could make guidelines more locally relevant. This would encourage more appropriate antibiotic prescribing and improve adherence. This would, in turn, potentially limit AMR development and improve patient outcomes.
引用
- Torumkuney D, Poojary A, Shenoy B, et al. Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome. J Antimicrob Chemother. 2022. PMID: 36065726. doi:10.1093/jac/dkac212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。